HemaSphere (Aug 2023)

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.

  • Andreas Hochhaus,
  • Andreas Burchert,
  • Susanne Saußele,
  • Gabriela M Baerlocher,
  • Jiri Mayer,
  • Tim H Brümmendorf,
  • Paul La Rosee,
  • Dominik Heim,
  • Stefan W Krause,
  • Philipp Le Coutre,
  • Christian Fabisch,
  • Jenny Rinke,
  • Thoralf Lange,
  • Alice Fabarius,
  • Marcel Lorch,
  • Mathias Hänel,
  • Frank Stegelmann,
  • Georg-Nikolaus Franke,
  • Markus Radsak,
  • Volker Kunzmann,
  • Danny Himsel,
  • Denise Kohn,
  • Thomas Lang,
  • Rüdiger Hehlmann,
  • Thomas Ernst,
  • Markus Pfirrmann

DOI
https://doi.org/10.1097/01.HS9.0000967540.46956.59
Journal volume & issue
Vol. 7
p. e4695659

Abstract

Read online

No abstracts available.